Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 51: 1605-1611, 2005. First published July 7, 2005; 10.1373/clinchem.2005.050120
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.050120v1
51/9/1605    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gofflot, S.
Right arrow Articles by Zorzi, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gofflot, S.
Right arrow Articles by Zorzi, W.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2005;51:1605-1611.)
© 2005 American Association for Clinical Chemistry, Inc.


Molecular Diagnostics and Genetics

Immunoquantitative PCR for Prion Protein Detection in Sporadic Creutzfeldt–Jakob Disease

Stéphanie Gofflot1, Manuel Deprez2, Benaïssa el Moualij1, Awad Osman3, Jean-François Thonnart1, Olivier Hougrand2, Ernst Heinen1 and Willy Zorzi1,a

1 Centre de Recherche sur les Protéines Prions (CRPP) - Service d’Histologie Humaine, Université de Liège-CHU, Liège, Belgium.
2 Laboratoire de Neuropathologie, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
3 Roboscreen GmbH, Leipzig, Germany.

aAddress correspondence to this author at: Centre de Recherche sur les Protéines Prions (CRPP), University of Liège, CHU B36 Tour de Pharmacie, Avenue de l’Hôpital 1, B-4000 Liège, Belgium. Fax 32-(0)4-3664321; e-mail willy.zorzi{at}ulg.ac.be.

Background: The most common human prion disorder is Creutzfeldt–Jakob disease (CJD); it includes sporadic, familial, iatrogenic, and variant subtypes. Diagnostic tests aim at detection with the highest specificity of very small deposits of abnormal prion protein (PrP).

Methods: We used immunoquantitative PCR (iqPCR) to detect proteinase K–resistant PrP (PrPRes) in tissue from the middle frontal gyrus of 7 patients with sporadic CJD and 7 non-CJD cases. We compared iqPCR with routine optimized ELISA, Western blotting, and immunohistochemical analyses.

Results: The 4 methods showed similar 100% sensitivity and specificity for the diagnosis of CJD. Along with high specificity, however, iqPCR had a threshold for PrPRes detection at least 10-fold lower than that of the classic ELISA.

Conclusions: iqPCR is a new method for PrPRes detection that combines 100% specificity with a detection threshold at least 10-fold lower than classic techniques. This method may improve the detection of minute PrPRes deposits in tissues and body fluids and thus be useful for diagnostic and sterilization applications.




The following articles in journals at HighWire Press have cited this article:


Home page
Appl. Environ. Microbiol.Home page
A. Rajkovic, B. E. Moualij, M. Uyttendaele, P. Brolet, W. Zorzi, E. Heinen, E. Foubert, and J. Debevere
Immunoquantitative Real-Time PCR for Detection and Quantification of Staphylococcus aureus Enterotoxin B in Foods
Appl. Envir. Microbiol., October 1, 2006; 72(10): 6593 - 6599.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.